Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US OTC > Medical - Equipment >

Titan Medical Inc. (TITXF)

Add TITXF Price Alert      Hide Sticky   Hide Intro
Moderator: glg20, drrc1949, investinthefuture, cptjsd, Longmoney, SPORT19
Search This Board: 
Last Post: 9/21/2017 10:10:43 PM - Followers: 278 - Board type: Free - Posts Today: 0

Titan Medical Partners With Florida Hospital Nicholson Center for SPORT Feasibility and Validation Studies

TORONTO, ON--(Marketwired - July 10, 2017) - Titan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (OTCQB: TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (MIS), announces a collaboration with Florida Hospital Nicholson Center for feasibility and validation studies to support Titan's regulatory application for its SPORT Surgical System. These studies are expected to commence in the fourth quarter of 2017 and continue into 2018.

David McNally, President and CEO of Titan Medical, said, "We are delighted to enter into this agreement with Florida Hospital Nicholson Center for continued feasibility and validation studies for the SPORT system. The Florida Hospital Nicholson Center is a world-class, state-of-the-art training and research facility with demonstrated leadership in robotic surgery innovation and training. With an accessible Orlando location, it has one of the country's largest and most experienced medical learning and simulation incubation centers dedicated to advancing next-generation clinical knowledge. Through this strategic alliance, Titan will also benefit from access to many leading multispecialty key opinion leaders and their surgical expertise in fine-tuning the SPORT system during this critical development phase."

"Florida Hospital Nicholson Center is one of three sites contemplated for our validation and feasibility studies. We look forward to engaging the other two sites during the current quarter, with completion of these studies in 2018," added Mr. McNally.

J. Scott Magnuson, MD, Chief Medical Officer of Florida Hospital Nicholson Center, said, "We are excited about helping Titan Medical benefit from the clinical expertise our institution offers in further refining their SPORT surgical system for regulatory submission. Our brand-new, 54,000-square-foot facility is a model for open collaborations to advance practices and standards across the entire spectrum of minimally invasive, laparoscopic, robotic, telemedicine and medical simulation. It is a place where innovators come together to build upon the brilliant work of industry pioneers to achieve breakthroughs that will revolutionize the way we perform surgery. We believe that Titan's single port surgical solution holds promise for continuing the surgical revolution."

About Florida Hospital Nicholson Center

For more than a decade, the Florida Hospital Nicholson Center has trained more than 50,000 physicians from around the globe on leading-edge clinical and surgical techniques. Utilizing state-of-the-art surgical suites and labs, plus advanced medical simulation robotics and learning centers, medical professionals can acquire and advance their skills in a highly collaborative surgical learning environment.

Titan Medical Insiders have purchased  $427,715 for the period March 16, 2017 - June 29, 2017.
An aggregate of 630,914 Units were issued to insiders of the Company under the Offering for gross proceeds of $220,819.  (March 16, 2017)
An aggregate of 1,445,973 Units were issued to insiders of the Company under the Offering for gross proceeds of $216,896, which included all of the Company's directors and officers.  (June 29, 2017)

SPORT™ Surgical System

A robotic system like no other!

The SPORT Surgical System is a versatile single incision advanced robotic surgical system that features state-of the-art multi-articulated instruments with single-use replaceable tips, 3D high definition visualization on a flat-screen monitor, ergonomic open workstation and a single-arm mobile patient cart for ease of set up while enabling broad applications of single and multi-quadrant surgeries previously not possible with current robotic solutions.

Titan Medical Inc. is a Canadian public company, headquartered in Toronto, Ontario, that trades on the Toronto Stock Exchange (TMD) and the OTCQX in the United States (TITXF). Titan is developing the SPORT™ (Single Port Orifice Robotic Technology) Surgical System for use in minimally invasive surgery (“MIS”) that is expected to be commercially available in 2019. Titan’s robotic surgical system is being designed to expand robotic surgery into areas that are currently underserviced. This will allow surgeons to perform procedures within small to medium size surgical spaces such as general surgery and cholecystectomy. Currently, the most common medical procedures for which robotic systems are used are hysterectomies and prostatectomies. Titan plans to expand the scope and obtain approval for various surgical procedures as outlined in their Corporate Presentation.

The SPORT™ Surgical System includes the following:
* a single-port surgeon controlled robotic platform that includes a 3D vision system and interactive instruments for performing MIS procedures, and

* a surgeon workstation that provides the surgeon with an interface to the robotic platform   for controlling the interactive instruments and providing a 3D endoscopic view of inside a patient’s body during MIS procedures.


David J. McNally, Chief Executive Officer, Director


Mr. McNally joins Titan after serving as the founder, President, CEO and Chairman of the Board of Domain Surgical Inc., founded in 2009, Domain is based in Salt Lake City, Utah. Mr. McNally brings substantial experience in areas of extraordinary leadership skills with all facets of building innovative medical device companies including clinically-focused product design and development, capital formation, regulatory clearance, and commercialization. Mr. McNally earned an MBA from the University of Utah, holds a Bachelor of Science degree in Mechanical Engineering from Lafayette College, Easton, PA and is the co-inventor of more than 30 U.S. and international patents associated with ferromagnetic surgical devices and systems, electromagnetic and ultrasonic sensors, and medical fluid delivery systems


                                                                                  Surgeon Advisory Board

Arnold Advincula, MD

Dr. Advincula is Vice-Chair of Women’s Health & Chief of Gynecology at the Sloane Hospital for Women, Columbia University Medical Center/New York Presbyterian Hospital. Formerly, he was Professor of Obstetrics and Gynecology, Director of the Minimally Invasive Surgery Division and Fellowship, and Director of the Endometriosis Center at the University of Michigan. More recently, he was Director of the Center for Specialized Gynecology and Director of the Education Institute at the Nicholson Center, an advanced medical and surgical simulation training facility at Florida Health. He is currently Vice President of the American Association of Gynecologic Laparoscopy and a Member-at-Large for the Society of Gynecologic Surgeons. He is a leader in minimally invasive surgical techniques and one of the world’s most experienced gynecologic robotic surgeons, who has published and taught extensively in the area of minimally invasive surgery, as well as developed surgical instruments that are in use worldwide.

Juliane Bingener-Casey, MD

Dr. Juliane Bingener is Professor of Surgery, Mayo Clinic College of Medicine, and Vice Chair for Quality, Safety and Service in the Mayo Clinic Department of Surgery. She has a joint appointment in the Division of Gastroenterology and Hepatology, which supports her clinical interests in minimally invasive surgery, endoscopy, and gastrointestinal disease. Her research focuses on patient reported outcomes and novel technology in the diagnosis and treatment of these diseases. Dr. Bingener’s previous work included the development of a Natural Orifice Translumenal Endoscopic Surgery (NOTES) technique for using an omental patch to close perforated ulcers. Her ongoing interests focus on the development, study, and implementation of innovative endoscopic and laparoscopic approaches for gastrointestinal diseases.

W. Douglas Boyd, MD

Dr. Boyd is a Professor of Surgery and Director of Robotics and Biosurgery at the University of California Davis. He is Head of Adult Cardiac Surgery and Surgical Director of the Transcatheter Valve Program. He is recognized for his pioneering work in cardiothoracic surgery and for his use of robotic-assisted surgical systems. He specializes in minimally invasive cardiac and robotic-assisted heart surgery. Dr. Boyd completed the world’s first closed-chest, beating-heart coronary artery bypass surgery using a robotic system in 1999. Prior to his appointment as a professor of surgery at UC Davis Health System, Dr. Boyd served as chair of the Department of Cardiothoracic Surgery at the Cleveland Clinic in Florida. As the author of more than 70 peer-reviewed, journal articles, Dr. Boyd’s research interests include cardiac tissue regeneration using extracellular matrix/stem cells, new techniques for robot-assisted minimally invasive coronary artery revascularization, valve surgery and tele-surgery. He is a graduate of Carleton University in Ottawa, Canada and obtained his medical degree from the University of Ottawa, Canada.

Demetrius EM Litwin, MD, MBA, FRCS, FACS, FICS

Dr. Litwin trained in General Surgery at the University of Saskatchewan, and completed a hepatobiliary fellowship at the University of Toronto. He was an early pioneer in laparoscopic surgery, having performed the first laparoscopic cholecystectomy in Western Canada in 1990 and the first laparoscopic colectomy in Canada in 1991. He was a leader in educating a large number of surgeons across Canada in basic and advanced laparoscopic techniques. During the early advent of minimally invasive surgery, he innovated new laparoscopic approaches to the spine and aorta, and he participated in the development of HandPortTM, a hand assist device for laparoscopic surgery. In 1993, Dr. Litwin became the Director of Minimally Invasive Surgery at the University of Toronto. In 1997, he moved to the University of Massachusetts as Chief of Minimally Invasive Surgery. Since 2004, he has been Chairman of Surgery at the University of Massachusetts Medical School and UMass Memorial Medical Center, one of the largest Academic Health Sciences Centers in Massachusetts. There, he continues to practice minimally invasive surgery of the abdomen in addition to his administrative role.

Lee L Swanstrom, MD, FACS

Dr. Swanstrom heads the Division of GI and Minimally Invasive Surgery at the Oregon Clinic and is Director of the Providence Health System’s Complex GI and Foregut Surgery Postgraduate Fellowship Program. In addition, he is Clinical Professor in the Department of Surgery at OHSU, a Director of the American Board of Surgery, and Past President of both the Society of American Gastrointestinal Endoscopic Surgeons (SAGES) and the Fellowship Council (FC). Most recently, he became the Chief Innovations Officer and Director of the Innovations Fellowship at the Institutes des Hôpitalo Universitaires of the University of Strasbourg, France. He is the editor of Surgical Innovation and the author of over 300 scientific papers and 50 book chapters. This has resulted in 13 patents and a successful medical device startup company. He is and has been an investigator on numerous outcomes research studies for new procedures such as Natural Orifice Translumenal Endoscopic Surgery (NOTES) to determine their safety and efficacy for establishing new standards of care. He remains focused on developing innovative approaches to the minimally invasive treatment of foregut and other gastrointestinal disorders.

John Valvo, MD

Dr. Valvo, a practicing surgeon, is the Executive Director of Robotic and Minimally Invasive Surgery at Rochester General Hospital in Rochester, New York, where he formerly was the Chief of Urology. Following a 20-year career performing open surgery, Dr. Valvo founded the robotic surgery program at Rochester General Hospital in early 2004, which currently ranks in the top two percent of robotic surgery volume in the United States. The program has trained over 30 robotic surgeons and enabled the completion of more than 7,000 robotic urology, gynecology, general and colorectal surgeries to date. Dr. Valvo has authored more than 100 scientific articles and helped start many robotic programs in the northeast. His focus on robotic surgery credentialing led to a notable published paper on policy guidelines for robotic surgery. He is a fellow of the American College of Surgeons and American Urological Association, and a member of the Society for Laparoscopic Surgeons. 






  Patent #                                                    Title of Invention
1 8,930,027   Force Feedback System
2 8,792,688   Methods, systems and devices for three dimensional input and control methods and systems based thereon
3 8,768,509   Snaking robotic arm with movable shapers
4 8,347,754   Multi articulating robotic instrument
5 8,332,072   Robotic hand controller
6 8,306,656   Method and system for performing medical procedure
7 8,224,485   Snaking robotic arm with movable shapers
8 5,853,394   Catheter
9 5,607,407   Catheter assembly
10 4,785,868   Medical needle and method for making
  PUB. APP. NO.  Title

Cannabis Stocks News
Interactive Brokers Advertisement
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#34285  Sticky Note Titan Medical Facebook Group SPORT19 03/19/16 10:14:24 AM
#59181   I think we gap up soon also! Looking forward SPORT19 09/21/17 10:10:43 PM
#59180   Still holding BABA myself. Stock has been a BigT82 09/21/17 10:05:08 PM
#59179   Welcome back! Interesting change of tune in a BigT82 09/21/17 10:03:04 PM
#59178   BACK IN THE GAME OR Nurse 09/21/17 09:28:31 PM
#59177   We'll know for sure soon enough! I have people Adrock 09/21/17 09:15:36 PM
#59176   I'm predicting a gap opening tomorrow morning. Let's roll Adrock 09/21/17 09:13:26 PM
#59174   Better yet, it's going to be harder and EIT 09/21/17 05:10:12 PM
#59173   Then there are a lot of coincidences to DRG1025 09/21/17 04:59:08 PM
#59172   But this time it's out there to behold QuidWilson 09/21/17 04:53:58 PM
#59171   That may not be true.. glg20 09/21/17 04:50:14 PM
#59170   The drastic increase in daily volume alone tells DRG1025 09/21/17 04:47:11 PM
#59169   That's great. Gonna be harder and harder for SPORT19 09/21/17 04:42:46 PM
#59168   it is so very tough to get to glg20 09/21/17 04:39:32 PM
#59167   None have been removed I changed my alias SPORT19 09/21/17 04:39:00 PM
#59166   Thank you sir! SPORT19 09/21/17 04:38:10 PM
#59164   Ask and you shall receive! Adrock 09/21/17 04:31:15 PM
#59163   Interesting press 9/15/17 for the case of Robotic Noemotionseller 09/21/17 04:30:22 PM
#59162   LinkedIn just informed me that news stories about investinthefuture 09/21/17 04:18:47 PM
#59161   Nicholson responding to posts on the LinkedIn page! SPORT19 09/21/17 04:01:29 PM
#59160   not complaining but there has to be a raise. glg20 09/21/17 03:54:57 PM
#59159   Another good day with over 1M shares traded. BigT82 09/21/17 03:35:28 PM
#59156   Florida Hospital Nicholson Center We are grateful for the investinthefuture 09/21/17 12:26:31 PM
#59155   I wonder how many of their 386 followers Trumpsnemesis1 09/21/17 12:23:55 PM
#59154   I'm not on LinkedIn, so what type things DRG1025 09/21/17 12:21:10 PM
#59153   Check out Florida Hospital's LinkedIn. They are busy investinthefuture 09/21/17 12:18:30 PM
#59149   The caption is a lie. She is 66Mustang 09/21/17 11:27:36 AM
#59147   Look at the caption under the stock photo QuidWilson 09/21/17 11:01:52 AM
#59146   Sorry... that was (obviously) the wrong link... 66Mustang 09/21/17 10:08:55 AM
#59145   Ha yea that's Titan Pharmaceuticals. Little early QuidWilson 09/21/17 10:00:07 AM
#59144   No good reason, just promoting SPORT! SPORT19 09/21/17 09:59:59 AM
#59143   That's the wrong Titan we are presenting at Adrock 09/21/17 09:54:54 AM
#59142   Why the name change, Jim? scalpel 09/21/17 09:54:16 AM
#59141   Thanks - for both links, AND the Cantor pmontx16 09/21/17 09:51:40 AM
#59140   If they're done with the design (which has QuidWilson 09/21/17 09:26:46 AM
#59139   If they only burned 1.1m for Q3 then either SPORT19 09/21/17 09:13:50 AM
#59138   Last post from me here for awhile...but I Honeycomb777 09/21/17 08:51:05 AM
#59137   According to this article, we have $8.9M cash QuidWilson 09/21/17 08:30:00 AM
#59136 66Mustang 09/21/17 08:26:09 AM
#59135  Restored 16 patents 43 patent applications SPORT units being installed SPORT19 09/21/17 06:19:34 AM
#59133   Funny how some positive movement brings out certain SPORT19 09/20/17 06:57:52 PM
#59132   Pmont, We shall toast in Vegas! You 66Mustang 09/20/17 06:42:25 PM
#59131   They should move the company to the US already!! SPORT19 09/20/17 04:42:13 PM
#59130   I am going to peek into my crystal Honeycomb777 09/20/17 04:41:37 PM
#59129   Hey Mustang we are on the same team, pmontx16 09/20/17 04:41:35 PM
#59128   Scalpel, You are absolutely correct, it was open to NoTshirt 09/20/17 04:24:58 PM
#59127   The way I see it were driving at QuidWilson 09/20/17 04:22:00 PM
#59126   Those numbers look good for a surgical robotic SPORT19 09/20/17 04:18:11 PM
#59125   Dude - Please read what you just posted...142M Honeycomb777 09/20/17 03:44:36 PM
#59123   We don't go from .10 to .15 at pontiacg6 09/20/17 03:10:14 PM
#59122   Next raise should come with special warrants to Honeycomb777 09/20/17 02:51:56 PM